CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Pulmonary Artery Denervation for Patients With Residual Pulmonary Hypertension After Pulmonary Endarterectomy Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification Evaluation and Management of Aortic Stenosis in Chronic Kidney Disease: A Scientific Statement From the American Heart Association Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study Low shear stress induces vascular eNOS uncoupling via autophagy-mediated eNOS phosphorylation Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease Pulmonary Hypertension Caused by a Coconut Left Atrium Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study) Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial Definition and Management of Segmental Pulmonary Hypertension

Original Research2017 May;89(6):955-963.

JOURNAL:Catheter Cardiovasc Interv. Article Link

Development and validation of a simple risk score to predict 30-day readmission after percutaneous coronary intervention in a cohort of medicare patients

Minges KE, Herrin J, Fiorilli PN et al. Keywords: Medicare; health care outcomes; percutaneous coronary intervention; quality improvement; risk stratification

ABSTRACT

OBJECTIVES - To develop a risk model that can be used to identify PCI patients at higher risk of readmission who may benefit from additional resources at the time of discharge.

 

BACKGROUND - A high proportion of patients undergoing PCI are readmitted within 30 days of discharge.

 

METHODS - The sample comprised patients aged 65 years who underwent PCI at a CathPCI Registry®-participating hospital and could be linked with 100% Medicare fee-for-service claims between 01/2007 and 12/2009. The sample (n = 388,078) was randomly divided into risk score development (n = 193,899) and validation (n = 194,179) cohorts. We did not count as readmissions those associated with staged revascularization procedures. Multivariable logistic regression models using stepwise selection models were estimated to identify variables independently associated with all-cause 30-day readmission.

 

RESULTS - The mean 30-day readmission rates for the development (11.36%) and validation (11.35%) cohorts were similar. In total, 19 variables were significantly associated with risk of 30-day readmission (P < 0.05), and model c-statistics were similar in the development (0.67) and validation (0.66) cohorts. The simple risk score based on 14 variables identified patients at high and low risk of readmission. Patients with a score of 13 (15.4% of sample) had more than an 18.5% risk of readmission, while patients with a score 6 (41.9% of sample) had less than an 8% risk of readmission.

 

CONCLUSION - Among PCI patients, risk of readmission can be estimated using clinical factors present at the time of the procedure. This risk score may guide clinical decision-making and resource allocation for PCI patients at the time of hospital discharge. © 2016 Wiley Periodicals, Inc.

 

© 2016 Wiley Periodicals, Inc.